|
2024
|
P/S
|
Medicines; pharmaceutical preparations for human use. |
|
|
Invention
|
Method of reducing the amount of n-nitrosamine impurities. A method for reducing the amount of ni... |
|
|
P/S
|
Pharmaceutical preparations for treatment of respiratory diseases; none of the aforementioned goo... |
|
|
P/S
|
medicines; pharmaceutical preparations for human use. |
|
|
P/S
|
Medicines; pharmaceutical preparations for treatment of respiratory diseases. |
|
|
Invention
|
Pharmaceutical composition containing vortioxetine. The present invention provides a pharmaceutic... |
|
2023
|
P/S
|
Medicines, pharmaceutical preparations for human use. |
|
|
P/S
|
Pharmaceutical preparations for human use; food supplements;
diagnostic preparations and materia... |
|
2021
|
Invention
|
Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing ... |
|
|
Invention
|
Pharmaceutical compositions comprising dasatinib anhydrous and uses thereof.
Pharmaceutical comp... |
|
|
Invention
|
Pharmaceutical compositions comprising dasatinib anhydrous and uses thereof. Pharmaceutical compo... |
|
|
P/S
|
Detergents having disinfectant properties for use in
manufacturing processes. Non-medicated toil... |
|
2020
|
P/S
|
Medicines, pharmaceutical preparations for human use;
dietetic food and substances adapted for m... |
|
|
Invention
|
Pharmaceutical compositions of abiraterone acetate. The invention provides immediate release phar... |
|
2018
|
Invention
|
Solid forms of tenapanor and method of preparation of tenapanor. The invention relates to solid f... |
|
|
Invention
|
Crystalline forms of (3α,5β,6α,7α)-6-ethyl-3,7-dihydroxycholan-24-ic acid. Crystalline form J-1 a... |
|
|
Invention
|
Solid forms of roxadustat. The solution relates to solid forms of roxadustat with the systematic ... |
|
|
Invention
|
Solid forms of elagolix. The invention provides novel solid forms of elagolix and its esters of f... |
|
|
Invention
|
A dosage unit with ppis (proton pump inhibitors). The present invention relates to a dosage unit ... |
|
|
Invention
|
Amorphous forms of obeticholic acid. The invention relates to solid forms of amorphous obeticholi... |
|
|
Invention
|
Film-coated tablets of deferasirox. The solution relates to a pharmaceutical composition in the f... |
|
2017
|
Invention
|
Crystalline forms of2-[1-ethylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidi... |
|
|
Invention
|
A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method there... |
|
|
Invention
|
Process for the production of a solid formulation of abiraterone acetate using the fluid granulat... |
|
|
Invention
|
Solid forms of eluxadoline. The object of the invention provides pharmaceutically acceptable soli... |
|
|
Invention
|
An amorphous form of sofosbuvir, a method of its preparation and its stabilization. The invention... |
|
|
Invention
|
Salts of lenvatinib. The present invention relates to solid forms of 4-[3-chloro-4- (cyclopropylc... |
|
|
Invention
|
A formulation of ixazomib citrate form 3. The invention relates to a pharmaceutical formulation c... |
|
|
Invention
|
Solid forms of ibrutinib. The invention relates to a solid form of 1-[(3R)-3-[4-Amino-3-(4-phenox... |
|
|
Invention
|
Crystalline modifications of methyl (3z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phen... |
|
|
Invention
|
A preparation method of diastereomerically pure tenofovir alafenamide or its salts. The invention... |
|
|
Invention
|
Crystalline modifications of methyl (3z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino} phe... |
|
|
Invention
|
Crystalline olaparib solvates with acetone, 2-propanol and/or methyl ethyl ketone. The invention ... |
|
2016
|
Invention
|
Crystalline forms of (3r)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4- yl)pyrazol-l-yl]propa... |
|
|
Invention
|
A preparation method of amorphous apremilast. The present invention relates to amorphous apremila... |
|
|
Invention
|
Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid e... |
|
|
Invention
|
Preparation of a drug form containing amorphous apixaban. The invention describes a preparation m... |
|
|
Invention
|
Crystalline form of canagliflozin and a method of its preparation. The invention relates to a new... |
|
|
Invention
|
A crystalline form of canagliflozin and a method of its preparation. The invention relates to a n... |
|
|
Invention
|
Pharmaceutical composition comprising the combination of candesartan, amlodipine and hydrochlorot... |
|
|
Invention
|
Preparation of intermediates for the synthesis of canagliflozin and dapagliflozin. The present in... |
|
|
Invention
|
A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4-yl)urea a... |
|
|
Invention
|
An amorphous form of vortioxetine hydrobromide stabilized by a cyclodextrin. The object of the in... |
|
|
Invention
|
Process for the preparation of ceritinib using "in situ" prepared 5-methyl-2-(1 -methylethoxy)-4-... |
|
|
Invention
|
A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4— yl)urea ... |
|
|
Invention
|
Crystalline form a of rilpivirine adipate and a method of its preparation. The invention relates ... |
|
|
Invention
|
Salts of 5-fluoro-3-phenyl-2-[(1s)-1-(9h-purin-6-ylamino)propyl]quinazolin-4-one and preparation ... |
|
|
Invention
|
Solid forms of amorphous dolutegravir. The solution relates to new solid forms of amorphous dolut... |
|
|
Invention
|
Method for preparing methyl (z)-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amin... |
|
|
Invention
|
Solid forms of ceritinib free base. The invention relates to solid forms of 5-chloro-N2-[2-isopro... |
|
|
Invention
|
A method for preparing methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl] amino]phenyl]am... |
|
|
Invention
|
A pharmaceutical composition containing valsartan and sacubitril and methods for preparation and ... |
|
|
Invention
|
Crystalline forms of obeticholic acid. Obeticholic acid is a semi-synthetic bile acid analogue wi... |
|
|
Invention
|
Crystalline forms of (3r)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propan... |
|
|
Invention
|
Ibrutinib hemisulphate. The invention relates to a novel crystalline solid form of ibrutinib in t... |
|
2015
|
Invention
|
Method of preparing vortioxetine. The new method of preparing 1-(2-(2,4-di-methylphenylsulphanyl)... |
